Navigation Links
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Date:11/6/2007

r injection 7.5 mg/mL. In adult patients, the recommended ABILIFY oral target dose is 15 mg to 30 mg/day in Bipolar I Disorder and 10 mg to 15 mg/day in schizophrenia. In adolescent patients with schizophrenia, the recommended ABILIFY oral target dose is 10 mg/day (with a starting dose of 2 mg/day which was titrated to 5 mg after 2 days and to the target dose of 10 mg after 2 additional days). The 30 mg/day dose was not shown to be more efficacious than the 10 mg/day dose. In adult patients with agitation associated with bipolar mania or schizophrenia, the ABILIFY Injection initial dose is 9.75 mg/1.3 mL. If ongoing ABILIFY therapy is clinically indicated, oral ABILIFY in a range of 10 mg to 30 mg/day should replace ABILIFY Injection as soon as possible. The safety of doses of ABILIFY oral or ABILIFY Injection above 30 mg/day has not been evaluated in clinical trials.

IMPORTANT SAFETY INFORMATION and INDICATIONS for ABILIFY

INDICATIONS:

-- ABILIFY is indicated for acute and maintenance treatment of

schizophrenia in adults

-- ABILIFY is indicated for the treatment of schizophrenia in adolescents

13 to 17 years of age

-- ABILIFY is indicated for acute and maintenance treatment of bipolar

disorder with or without psychotic features

ABILIFY Injection is indicated for the treatment of adults with agitation associated with schizophrenia or bipolar disorder, manic or mixed.

IMPORTANT SAFETY INFORMATION:

Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. ABILIFY is not approved for the treatment of patients with dementia-related psychosis (see Boxed WARNING).

Cerebrovascular adverse events (eg, stroke, transient ischemic attack),

including fatalities, have been reported at an increased incidence in

clinical trials of elderly patients with dementia-related psychosis

treate
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
2. Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees
3. Wells Fargo Offers Online Benefit Administration for Business and Individual Healthcare Consumers
4. Administration Anesthetized to Ailments of Nations Children
5. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
6. Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check
7. FDA Approves First Anti-Psychotic for Kids
8. FDA Approves New Roche West Nile Virus Blood Screening Test
9. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
10. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
11. FDA Approves SOMA(R) (carisoprodol) 250 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Maintaining proper oral hygiene is just as important for ... In recent years, many different products have become available to ... white. Royal Flush Havanese shares with readers some ... while choosing the top products that are the most effective. ... in a dog’s mouth, causing bad breath. This can also ...
(Date:7/23/2014)... New York, NY (PRWEB) July 23, 2014 ... to 2 billion dollars by the year 2020, according ... the skin are among the top sellers in the ... products. The best wrinkle cream under $100 is now ... is meant to help a first-time or experienced shopper ...
(Date:7/23/2014)... The puffiness that can appear underneath ... according to a new guide published at the CherryNews.com ... the U.S. is now available for men and women ... guide that is now published is meant to provide ... puffiness. While surgical techniques are available, there are all-natural ...
(Date:7/23/2014)... scientist from the University of Exeter has developed ... diagnosing a frequently fatal lung disease which attacks ... bone marrow transplant recipients. , The lateral-flow device ... pulmonary aspergillosis, a notoriously difficult to diagnose disease ... , Invasive aspergillosis is a leading ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
Breaking Medicine News(10 mins):Health News:Royal Flush Havanese Reviews Tips on Proper Dental Care For Canines 2Health News:Royal Flush Havanese Reviews Tips on Proper Dental Care For Canines 3Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:New device detects deadly lung disease 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3
... comeback. Recently published case series have shown encouraging ... treatment-resistant obsessive-compulsive disorder, depressive disorders, and Tourette syndrome. ... International , authors Jens Kuhn (University of Cologne) ... Cologne) and their co-authors provide an introduction to ...
... ... America , ... MD (Vocus) March 2, 2010 -- As Maryland Gov. Martin O’Malley proposes cutting $123 million ... year 2010, a new study by Dr. Todd Eberly, assistant professor of political science and ...
... ... for the Cure® events across the country. , ... Collegedale, TN (Vocus) March 4, 2010 -- Sunbelt ® is pleased to announce ... , , , , ,“The Sunbelt employees who volunteered and participated in last year’s events had ...
... , ... ... , ... , , ...
... ... ... ... ...
... ... Month, Independence-based preventive health screening provider offers discounted FDA-approved home tests kits for colorectal ... Independence, ... kits for colorectal cancer for a discounted price of $15. Neighborhood screenings can ...
Cached Medicine News:Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 2Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 3Health News:Sunbelt Announces Renewed Commitment to Breast Cancer Awareness 2Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 2Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 3Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 4Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 5Health News:Essilor - 2009 Financial Results 2Health News:Essilor - 2009 Financial Results 3Health News:Essilor - 2009 Financial Results 4Health News:Essilor - 2009 Financial Results 5Health News:Essilor - 2009 Financial Results 6Health News:Essilor - 2009 Financial Results 7Health News:Essilor - 2009 Financial Results 8Health News:Essilor - 2009 Financial Results 9Health News:Essilor - 2009 Financial Results 10Health News:Essilor - 2009 Financial Results 11Health News:Essilor - 2009 Financial Results 12Health News:Essilor - 2009 Financial Results 13Health News:Essilor - 2009 Financial Results 14Health News:Essilor - 2009 Financial Results 15Health News:Essilor - 2009 Financial Results 16Health News:Essilor - 2009 Financial Results 17Health News:Essilor - 2009 Financial Results 18Health News:Essilor - 2009 Financial Results 19Health News:Essilor - 2009 Financial Results 20Health News:Life Line Screening Offers Special Pricing on Colorectal Home Test Kits in Honor of National Colorectal Cancer Month 2
(Date:7/23/2014)... NORWALK, Conn. , July 23, 2014 ... NeurologyTimes.com – a new online community and information ... them better manage and treat their patients with ... conditions, coupled with an aging population, necessitates greater access ... specific disorders.  Key statistics on neurological conditions include: ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC announced ... chief customer officer effective immediately. Toll recently served as ... and marketing, category management, private label and sales administration ... his new global role, Toll will expand his responsibilities ... planning. "Toll,s appointment to chief customer officer ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... addition of the "Global Electrophysiology Ablation Catheters ... http://photos.prnewswire.com/prnh/20130307/600769 ... to remove or destroy faulty electrical pathways from ... rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... , , MOUNTAIN VIEW, Calif., Dec. 29 ... developing innovative, next-generation medical therapies to address unmet needs in ... Drug Application (NDA) has been submitted to the U.S. Food ... drug for the treatment of obesity, including weight loss and ...
... , , REDWOOD CITY, Calif., Dec. 28 Codexis, ... Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The shares of common stock to be sold in ... certain of its stockholders. , Credit Suisse Securities (USA) LLC and ...
Cached Medicine Technology:VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 2VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 3VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 4VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 5Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Operating microscope with motorized zoom and variable focus up to 405 mm....
... Opmi Vario/NC33 system microscope provides surgeons with ... These microscopes are ideal for many minimally ... Ergonomically designed at every point of contact. ... in a surgical microscope allows intuitive user ...
Curved left, Hardy Curettes, bayonet, working distance 120 mm, total length 241 mm....
Toothed pituitary rongeur. Straight....
Medicine Products: